The ANA Has Recognized PBM Nursing as a Specialty. Here Is What Health Systems Need to Do Now.

By Sherri Ozawa, MSN, RN
Share

Clinical Strategy

The ANA Has Recognized PBM Nursing as a Specialty. Here Is What Health Systems Need to Do Now.

On June 17, 2026, the American Nurses Association Board of Directors formally recognized Patient Blood Management (PBM) nursing as a nursing specialty, approved the submitted PBM Nursing Scope of Practice Statement, and acknowledged the specialty standards and accompanying competencies.

This is not a symbolic designation. It creates a formal career pathway for PBM nurses, a defined credentialing framework, and a clearer standard against which health systems will be measured. The question is not whether to respond. It is how quickly and how well.

Key Takeaways

  • The ANA formally recognized Patient Blood Management nursing as a nursing specialty, approving its scope of practice, standards, and competencies
  • Fewer than 100 U.S. hospitals currently operate formal anemia management programs, leaving most health systems without the infrastructure the new specialty demands
  • AI-powered clinical intelligence platforms like hc1 Clinical IQ™ can help health systems close that gap, reducing transfusion rates, avoiding complications, and generating documented ROI.
  • Health systems that build robust PBM programs now will gain a competitive advantage in talent recruitment, accreditation, and payer conversations

Why This Recognition Matters

PBM nursing recognition gives health systems a clear framework for building, credentialing, and sustaining PBM nursing roles. That matters because the scale of the problem demands a specialized, accountable response.

30-40%

of all blood transfusions remain unnecessary, excessive, or avoidable

40%

of major surgery patients arrive anemic, the most common indication for transfusion

<100

U.S. hospitals have formal anemia management programs today

Patient Blood Management is defined by the Society for the Advancement of Patient Blood Management (SABM) as a patient-centered, systematic, evidence-based approach to improving patient outcomes by managing and preserving the patient’s own blood, while promoting patient safety and empowerment. That definition has guided clinical practice for years. What has been missing is the professional infrastructure to match it. The ANA’s recognition begins to provide that infrastructure.

PBM nurses are positioned to address each of these realities directly. But without the data, technology, and institutional support to act at scale, even highly skilled PBM professionals can only move so far.


The Infrastructure Gap Most Health Systems Have Not Closed

Across the United States, fewer than 100 hospitals have formal anemia management programs, according to industry estimates. Most health systems that have formed PBM committees still rely on manual care coordination, fragmented internal data, and reactive transfusion monitoring – reviewing what happened rather than preventing what is about to.

The barriers are predictable. Clinicians are stretched thin. Data lives in disconnected systems. Building a sustainable program infrastructure takes time and expertise that most organizations cannot spare. Many committees do the minimum: monitoring blood component spend and utilization while the most significant drivers of transfusion overuse go unaddressed.


How hc1 Clinical IQ Supports the PBM Nursing Specialty

hc1 Clinical IQ empowers clinical and quality leaders to reduce practice variation and close care gaps at scale. The platform surfaces risk, automates workflows, and connects care teams with recognized PBM clinical experts. Two capabilities are directly relevant to PBM nursing programs.

hc1 Patient Blood Management

A Comprehensive Program Approach

hc1’s comprehensive PBM solution combines benchmarking and analytics with hands-on support from internationally recognized clinical experts. hc1 has implemented PBM programs at more than 450 hospitals, consistently reducing blood use by 20+%.

The approach is built on five fundamentals:

  • Establishing a clinically driven, multidisciplinary PBM program infrastructure
  • Developing and distributing meaningful PBM reports at the hospital, specialty, and provider level
  • Implementing evidence-based transfusion guidelines with clinical decision support
  • Rolling out ongoing, customized clinical education and awareness campaigns
  • Implementing strategies to improve anemia recognition, management, and blood loss minimization

These fundamentals are not theoretical. They are the operational backbone of programs already running – and already producing results – across hundreds of health systems.

Automated Anemia Management

hc1’s patented, EHR-integrated MyBloodHealth platform addresses one of the most persistent gaps in perioperative care: identifying and treating anemic patients before they reach the operating room.

MyBloodHealth runs continuously through EHR integration, automatically flagging surgical and obstetric patients with evidence of anemia, triaging by urgency, and generating individualized care plans for provider review. This automated approach allows providers to treat four times more patients than manual processes allow.

Through 2024, 194,520 patients at 70 U.S. hospitals were automatically enrolled in MyBloodHealth-powered programs (hc1 internal data, 2024). Among treated anemic patients, outcomes included an 83% reduction in transfusion rates and a 91% reduction in readmission rates.

Together, these capabilities support 75% of the PBM accreditation measures set by The Joint Commission and AABB – a direct alignment with the professional standards the ANA has now formalized.


Documented Outcomes Across 350+ Health Systems

hc1 Clinical IQ’s PBM outcomes are documented performance, not projections.

  • $120 million-plus in blood acquisition cost savings through the Comprehensive PBM solution
  • 260% ROI over three years
  • 8,000-plus blood transfusion complications avoided
  • 1,900-plus transfusion-associated deaths prevented

The Clinical IQ Impact

One Pennsylvania health system implemented hc1’s comprehensive PBM program in early 2022. Within nine months, the system enrolled 2,241 patients, identified 651 anemic patients, and achieved $330,000 in blood acquisition cost savings – an 18% cost reduction. Monthly margin improvement grew from an initial projection of $10,000 to $28,000 and continued climbing.


What This Means for Health System Strategy

The ANA’s recognition creates a defined professional identity for PBM nurses and raises the bar for the health systems that employ them. For executives, the strategic implications are concrete.

Recruitment and retention of PBM-specialized nursing talent will become a competitive differentiator.
Accreditation programs aligned with PBM standards will carry growing weight in quality metrics and payer conversations.
Health systems without robust PBM infrastructure will face increasing exposure to avoidable costs, complications, and care variation.

hc1 Clinical IQ is designed to support that infrastructure directly. The platform gives PBM nurses the intelligence they need to work at the full scope of their specialty, and gives health system leaders the measurable outcomes that accreditation and performance standards require.


Frequently Asked Questions

What does ANA recognition of PBM nursing mean for health systems?+

The ANA’s June 2026 recognition formally defines the scope of practice, competency standards, and career pathway for PBM nurses. For health systems, it creates a clearer framework for credentialing PBM nursing roles and a stronger mandate to build the program infrastructure that specialty practice requires.

How many U.S. hospitals have a formal PBM program?+

Industry estimates put the number at fewer than 100 hospitals with formal anemia management programs. Most health systems that have formed PBM committees still rely on manual processes and reactive monitoring rather than proactive, data-driven management.

What is the ROI of a Patient Blood Management program?+

hc1 Clinical IQ’s documented outcomes include 260% ROI over three years, $120 million-plus in blood acquisition cost savings, and $250 million-plus in total savings across 300 health systems. Individual health system results vary based on baseline utilization, program scope, and implementation depth.

What is the difference between a PBM program and a transfusion committee?+

A transfusion committee typically reviews blood component spend and utilization retrospectively. A full PBM program adds proactive anemia screening, evidence-based transfusion guidelines with clinical decision support, provider-level reporting, and structured education – addressing the root causes of transfusion overuse rather than monitoring after the fact.

How does hc1 Clinical IQ support PBM accreditation?+

hc1 Clinical IQ’s capabilities support 75% of the PBM accreditation measures set by The Joint Commission and AABB. This includes benchmarking, clinical decision support, and automated anemia management through the MyBloodHealth platform.


Ready to assess where your cPBM program stands?

hc1 Clinical IQ has helped hundreds of health systems build, scale, and sustain PBM programs with documented clinical and financial results. No obligation. Just a clear picture of where your program stands and what is possible.

Request Your Free Assessment

For more on the PBM nursing specialty and the broader movement advancing patient blood safety, visit SABM (sabm.org) and World Anemia Awareness (worldanemiaawareness.com).